IBD patients have been found to have a higher risk of lymphoma.

Published Date: 26 Apr 2023

According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.

Read Full News

Latest News

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

AGA Urges Caution Around Surgery for Refractory Constipation in Clinical Practice Update

AGA Urges Caution Around Surgery for Refractory Constipation in Clinical Practice Update

Alcohol-Related Chronic Pancreatitis Linked to Better Outcomes Than Non-Alcohol-Related Disease

Alcohol-Related Chronic Pancreatitis Linked to Better Outcomes Than Non-Alcohol-Related Disease

EBX-102-02 Shows Benefit for IBS-C and IBS-D in Phase 2a TrIuMPH Trial

EBX-102-02 Shows Benefit for IBS-C and IBS-D in Phase 2a TrIuMPH Trial

Q4 2025 Recap: Gastroenterology News and Updates

Q4 2025 Recap: Gastroenterology News and Updates

5 Gastroenterology Headlines You Missed in December 2025

5 Gastroenterology Headlines You Missed in December 2025

Todays Updates

Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival Marco Meglio

Published phase 3 data in JAMA Neurology highlighted tofersen's potential to slow ALS progression and improve survival, marking a breakthrough in SOD1-ALS treatment.

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Todays Updates

Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival Marco Meglio

Published phase 3 data in JAMA Neurology highlighted tofersen's potential to slow ALS progression and improve survival, marking a breakthrough in SOD1-ALS treatment.

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Latest News

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

AGA Urges Caution Around Surgery for Refractory Constipation in Clinical Practice Update

Alcohol-Related Chronic Pancreatitis Linked to Better Outcomes Than Non-Alcohol-Related Disease

EBX-102-02 Shows Benefit for IBS-C and IBS-D in Phase 2a TrIuMPH Trial

Q4 2025 Recap: Gastroenterology News and Updates

5 Gastroenterology Headlines You Missed in December 2025

News All Time

AI Tools Fall Short for Dietary Recommendations for Managing IBS

AI Tools Fall Short for Dietary Recommendations for Managing IBS

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

Reducing Diagnostic Delays and Improving Follow-Up Care for EoE, With Rosa Yu, MD

Reducing Diagnostic Delays and Improving Follow-Up Care for EoE, With Rosa Yu, MD

LUCENT-3: Mirikizumab (Omvoh) Shows Sustained Benefit in Ulcerative Colitis Through 4 Years Abigail Brooks, MA

LUCENT-3 open-label extension study data establish mirikizumab-mrkz (Omvoh) as the first and only IL-23p19 to show sustained long-term outcomes in UC through 4 years.

Small Intestine Dilation Links to Food-Protein-Induced Enterocolitis Syndrome Chelsie Derman

A recent study reveals that small intestinal dilation significantly contributes to abdominal symptoms in adults with Food-Protein-Induced Enterocolitis Syndrome (FPIES).

The HCPFive: Top News for Healthcare Providers from the Week of 10/05 HCPLive Editorial Staff

Stay updated with the latest healthcare breakthroughs, including FDA approvals and clinical trial readouts, in this week's essential news roundup.

HCPLive 5 Stories in Under 5: Week of 10/05 Victoria Johnson

An audio recap of the top 5 stories in healthcare news from the week of 10/5-10/11.

FDA Approves Updated Indication for Upadacitinib (Rinvoq) in IBD Abigail Brooks, MA

The decision updates the indication statements for ulcerative colitis and Crohn’s disease to allow use in patients who have received ≥ 1 approved systemic therapy.

Empirical Donor Selection, 2-Dose Capsule FMT Regimen Improve C Diff Cure Rates Abigail Brooks, MA

Findings from the quality improvement study provide real-world data supporting empirical donor exclusion and multiple-dose capsule FMT to increase CDI cure rates.

ACP Releases Position Paper on Colorectal Cancer Screening, Surveillance Abigail Brooks, MA

The ACP Performance Measurement Committee reviewed 5 performance measures for CRC screening, ultimately only supporting 1 of them.

Conference Preview: American College of Gastroenterology’s 2025 Annual Scientific Meeting Abigail Brooks, MA

View slated expert interviews and 6 clinical GI, hepatology, and endoscopy trials to watch at ACG 2025.

GERD Linked To Heightened Risk of New Alcohol Use Disorder Diagnosis Abigail Brooks, MA

Findings suggest having GERD incurs an 18% greater risk of a new AUD diagnosis, presenting an opportunity to discuss alcohol use with patients.

Emphasizing Bone Health Screening in GI, With Alexandria Markley, MD Alexandria Markley, MD

Markley describes the importance of monitoring bone health in patients with IBD and celiac disease and explains her research showing low screening rates.

Demographic Disparities in GLP-1 RA Trial Enrollment Raise Inclusivity, Validity Concerns Abigail Brooks, MA

Despite bearing a greater obesity burden, Black, Hispanic, and American Indian/Native individuals are underrepresented in GLP-1 RA RCTs for weight loss.

FDA Approves Single-Dose Formulation of Mirikizumab-mrkz for Ulcerative Colitis Ryan Livingston

FDA approves Omvoh (mirikizumab-mrkz) for monthly maintenance of ulcerative colitis, simplifying treatment for patients with this chronic condition.

Solidifying Dupilumab’s Role in Eosinophilic Esophagitis Care, With Evan Dellon, MD, MPH Evan Dellon, MD, MPH

Dellon reviews data from a post-hoc analysis of dysphagia and odynophagia in LIBERTY EoE TREET and a pooled analysis of endoscopic improvement in 2 trials.

Recommended News For You

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations

Enhanced CAR T cell therapy offers new strategy for lymphoma

Exercise can counter detrimental effects of cancer treatment, review suggests

What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

Recommended Articles For You

Revolutionizing Cancer Care with Fulphila: A New Hope for Patients 

Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care 

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders 

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI tool identifies women at high risk of interval breast cancer

2.

Best foot forward—chemo care should include podiatry, say researchers

3.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

4.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

5.

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

1.

Cancer in 2024: Global Trends, Challenges, and Innovations for Healthcare Professionals

2.

The Unseen Threat: Uncovering the Risks of Pancoast Tumor

3.

From Muscle Soreness to Improved Endurance: The Benefits of Monitoring Lactic Acid Levels 

4.

Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment

5.

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

2.

Navigating the Complexities of Ph Negative ALL - Part I

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

4.

Updates on the First Line Management of ALK+ NSCLC

5.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot